Pharmaceuticals, Biotechnology and Life Sciences
TYRVAYA(TM) (varenicline solution) TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg is now available at U.S. regional wholesalers for distribution to…
Phase 1 data from Gritstone-sponsored CORAL study (SARS-CoV-2 second generation vaccine utilizing self-amplifying mRNA boost) expected in early Q1 2022;…
EMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen” or the “Company”), a leading biofacturing company, today reported…
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer…
CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX | NASDAQ: XRTX),…
MALVERN, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and…
Lille, France; Cambridge, MA; November 02, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
IRVINE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on…